# MARGENZA

NDC: 70720-022
Generic name: margetuximab-cmkb
Labeler / Manufacturer: TerSera Therapeutics LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20210115

FDA application: BLA761150

## Active ingredients

- MARGETUXIMAB: 25 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70720-022"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70720-022
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6a6d50c7-06ea-479c-83cc-f197a9e428c9